NCT02148211View on ClinicalTrials.gov

Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry

CompletedOBSERVATIONAL
Enrollment

507

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Influenza
Interventions
OTHER

Data collection

Initial and follow-up data was collected using questionnaires.

Trial Locations (1)

284013331

GSK Investigational Site, Wilmington

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02148211 - Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry | Biotech Hunter | Biotech Hunter